MDGL's three largest insider shareholders as of May 30, 2026 are Bros. Advisors Lp Baker (Director, 1.86Mn shares), Rebecca Taub (Pres., Rd, And Cmo, 452.21K shares), Fred B Craves (Director, 350.08K shares).
| Holder | Position | Shares (Direct) | Shares (Indirect) | Report Date |
|---|---|---|---|---|
| Fred B Craves | - | 350,076 | 0 | 14 Mar, 2025 |
| Kenneth Bate | - | 2,627 | 0 | 07 Nov, 2025 |
| Paul A Friedman | Chief Executive Officer | 187,164 | 0 | 13 Jan, 2026 |
| Bros. Advisors Lp Baker | - | 0 | 1,859,091 | 20 Aug, 2025 |
| Jacqualyn A Fouse | - | 1,097 | 0 | 24 Jun, 2025 |
| Rebecca Taub | Pres., Rd, And Cmo | 452,213 | 0 | 06 Mar, 2026 |
| Richard S Levy | - | 27,697 | 0 | 24 Feb, 2026 |
| William John Sibold | President And Ceo | 161,829 | 0 | 06 Mar, 2026 |
| James M Daly | - | 2,627 | 0 | 24 Jun, 2025 |
| Mardi Dier | Evp And Cfo | 12,490 | 0 | 06 Mar, 2026 |
| David Soergel | Chief Medical Officer | 11,919 | 0 | 06 Mar, 2026 |
| Daniel J. Brennan | - | 967 | 0 | 05 Aug, 2025 |
| Brian Joseph Lynch | Svp And General Counsel | 17,691 | 0 | 25 Jan, 2024 |
| Alex G. Howarth | Chief Financial Officer | 18,737 | 0 | 25 Jan, 2024 |
| Remy Sukhija | Chief Commercial Officer | 15,001 | 0 | 18 Jan, 2023 |
| Robert E. Waltermire | Senior Vp, Chief Pharma Dev. | 5,789 | 0 | 07 Mar, 2025 |
| Carole Huntsman | Chief Commercial Officer | 12,692 | 0 | 06 Mar, 2026 |
| Shannon T Kelley | General Counsel | 12,138 | 0 | 06 Mar, 2026 |
| Rita Thakkar | Chief Accounting Officer | 2,398 | 0 | 20 Jan, 2026 |
* Please note that the shares above only reflect shares from the fund portfolio and the institutional portfolio. Shares from the personal portfolio are excluded from this Institutional Ownership Page. See these insiders' latest transactions here on Insider Page.
| Transaction Date | Insider Name | Security Class | Transaction Type | Shares Traded | Price | Shares Remaining | Ownership | Code |
|---|---|---|---|---|---|---|---|---|
| 04 Mar, 2026 | Shannon T Kelley | Common Stock | A | 4,017 | $0.00 | 12,498 | D | A |
| 04 Mar, 2026 | Carole Huntsman | Common Stock | A | 3,989 | $0.00 | 13,111 | D | A |
| 04 Mar, 2026 | William John Sibold | Common Stock | A | 14,995 | $0.00 | 163,492 | D | A |
| 06 Mar, 2026 | Rebecca Taub | Common Stock | D | 491 | $431.94 | 452,213 | D | S |
| 04 Mar, 2026 | Mardi Dier | Common Stock | A | 5,215 | $0.00 | 14,472 | D | A |
| 04 Mar, 2026 | William John Sibold | Common Stock | A | 14,995 | $0.00 | 163,492 | D | A |
| 04 Mar, 2026 | David Soergel | Common Stock | A | 4,374 | $0.00 | 11,919 | D | A |
| 06 Mar, 2026 | William John Sibold | Common Stock | D | 1,663 | $431.94 | 161,829 | D | S |
| 06 Mar, 2026 | William John Sibold | Common Stock | D | 1,663 | $431.94 | 161,829 | D | S |
| 04 Mar, 2026 | David Soergel | Stock Option (Right to Buy) | A | 5,467 | $0.00 | 5,467 | D | A |
| 06 Mar, 2026 | Mardi Dier | Common Stock | D | 646 | $431.94 | 13,826 | D | S |
| 06 Mar, 2026 | Shannon T Kelley | Common Stock | D | 360 | $431.94 | 12,138 | D | S |
| 06 Mar, 2026 | Carole Huntsman | Common Stock | D | 419 | $431.94 | 12,692 | D | S |
| 06 Mar, 2026 | Mardi Dier | Common Stock | D | 40 | $425.08 | 13,786 | D | S |
| 04 Mar, 2026 | William John Sibold | Stock Option (Right to Buy) | A | 18,743 | $0.00 | 18,743 | D | A |
| 04 Mar, 2026 | William John Sibold | Stock Option (Right to Buy) | A | 18,743 | $0.00 | 18,743 | D | A |
| 04 Mar, 2026 | Shannon T Kelley | Stock Option (Right to Buy) | A | 5,022 | $0.00 | 5,022 | D | A |
| 04 Mar, 2026 | Carole Huntsman | Stock Option (Right to Buy) | A | 4,986 | $0.00 | 4,986 | D | A |
| 06 Mar, 2026 | Mardi Dier | Common Stock | D | 420 | $426.86 | 13,366 | D | S |
| 06 Mar, 2026 | Mardi Dier | Common Stock | D | 80 | $427.85 | 13,286 | D | S |